Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Time to publication for publicly funded clinical trials in Australia: an observational study.

Strand LB, Clarke P, Graves N, Barnett AG.

BMJ Open. 2017 Mar 22;7(3):e012212. doi: 10.1136/bmjopen-2016-012212.

2.

A Review of Skull Base Tumor Clinical Trials: Past Trends and Future Opportunities.

Devaiah A, Murchison C.

J Neurol Surg B Skull Base. 2017 Apr;78(2):116-119. doi: 10.1055/s-0036-1586759. Epub 2016 Aug 24.

PMID:
28321373
3.

Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?

Jones CW, Braz VA, McBride SM, Roberts BW, Platts-Mills TF.

BMJ Open. 2016 Nov 24;6(11):e013649. doi: 10.1136/bmjopen-2016-013649.

4.
5.

Systematic review protocol assessing the processes for linking clinical trial registries and their published results.

Bashir R, Dunn AG.

BMJ Open. 2016 Oct 3;6(10):e013048. doi: 10.1136/bmjopen-2016-013048.

6.
7.

Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide.

van Valkenhoef G, Loane RF, Zarin DA.

Syst Rev. 2016 Jul 15;5(1):116. doi: 10.1186/s13643-016-0283-8.

8.

Association between trial registration and treatment effect estimates: a meta-epidemiological study.

Dechartres A, Ravaud P, Atal I, Riveros C, Boutron I.

BMC Med. 2016 Jul 4;14(1):100. doi: 10.1186/s12916-016-0639-x.

9.

Clinical trials in allied medical fields: A cross-sectional analysis of World Health Organization International Clinical Trial Registry Platform.

Kannan S, Gowri S.

J Ayurveda Integr Med. 2016 Mar;7(1):48-52. doi: 10.1016/j.jaim.2015.09.003. Epub 2016 May 24.

10.

Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials.

Bourgeois FT, Olson KL, Tse T, Ioannidis JP, Mandl KD.

PLoS One. 2016 May 19;11(5):e0155948. doi: 10.1371/journal.pone.0155948. eCollection 2016.

11.

Italian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases.

Traversa G, Masiero L, Sagliocca L, Trotta F.

Orphanet J Rare Dis. 2016 Apr 12;11:36. doi: 10.1186/s13023-016-0420-4.

12.

Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.

Massey PR, Wang R, Prasad V, Bates SE, Fojo T.

Oncologist. 2016 Mar;21(3):261-8. doi: 10.1634/theoncologist.2015-0516. Epub 2016 Feb 17.

13.

Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers.

Chen R, Desai NR, Ross JS, Zhang W, Chau KH, Wayda B, Murugiah K, Lu DY, Mittal A, Krumholz HM.

BMJ. 2016 Feb 17;352:i637. doi: 10.1136/bmj.i637.

14.

Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.

Baudart M, Ravaud P, Baron G, Dechartres A, Haneef R, Boutron I.

BMC Med. 2016 Jan 28;14:7. doi: 10.1186/s12916-016-0551-4.

16.

Comparison of registered and published outcomes in randomized controlled trials: a systematic review.

Jones CW, Keil LG, Holland WC, Caughey MC, Platts-Mills TF.

BMC Med. 2015 Nov 18;13:282. doi: 10.1186/s12916-015-0520-3. Review.

17.
18.
19.

Risks of phase I research with healthy participants: A systematic review.

Johnson RA, Rid A, Emanuel E, Wendler D.

Clin Trials. 2016 Apr;13(2):149-60. doi: 10.1177/1740774515602868. Epub 2015 Sep 8. Review.

20.

FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study.

Marin Dos Santos DH, Atallah ÁN.

PeerJ. 2015 Jun 25;3:e1015. doi: 10.7717/peerj.1015. eCollection 2015.

Supplemental Content

Support Center